This table contains 2394 series, with data for years 1991 - 1991 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Population group (19 items: Entire cohort; Income adequacy quintile 1 (lowest);Income adequacy quintile 2;Income adequacy quintile 3 ...), Age (14 items: At 25 years; At 30 years; At 40 years; At 35 years ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: Life expectancy; High 95% confidence interval; life expectancy; Low 95% confidence interval; life expectancy ...).

Life expectancy at birth and at age 65, by sex, on a three-year average basis.

Life expectancy at birth, male (years) in Canada was reported at 79.51 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Canada - Life expectancy at birth, male (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

This table contains 2754 series, with data for years 2005/2007 - 2012/2014 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (153 items: Canada; Newfoundland and Labrador; Eastern Regional Integrated Health Authority, Newfoundland and Labrador; Central Regional Integrated Health Authority, Newfoundland and Labrador; ...);  Age group (2 items: At birth; At age 65);  Sex (3 items: Both sexes; Males; Females);  Characteristics (3 items: Life expectancy; Low 95% confidence interval, life expectancy; High 95% confidence interval, life expectancy).

This table contains mortality indicators by sex for Canada and all provinces except Prince Edward Island. These indicators are derived from three-year complete life tables. Mortality indicators derived from single-year life tables are also available (table 13-10-0837). For Prince Edward Island, Yukon, the Northwest Territories and Nunavut, mortality indicators derived from three-year abridged life tables are available (table 13-10-0140).

Canada CA: Life Expectancy at Birth: Total data was reported at 81.647 Year in 2023. This records an increase from the previous number of 81.245 Year for 2022. Canada CA: Life Expectancy at Birth: Total data is updated yearly, averaging 77.649 Year from Dec 1960 (Median) to 2023, with 64 observations. The data reached an all-time high of 82.164 Year in 2019 and a record low of 71.133 Year in 1960. Canada CA: Life Expectancy at Birth: Total data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.;(1) United Nations Population Division. World Population Prospects: 2024 Revision; or derived from male and female life expectancy at birth from sources such as: (2) Statistical databases and publications from national statistical offices; (3) Eurostat: Demographic Statistics.;Weighted average;

This table contains mortality indicators for Canada and provinces for the period 1980/1982 to 2013/2015. Complete mortality tables are available for men, women and both sexes combined.

Number of deaths and mortality rates, by age group, sex, and place of residence, 1991 to most recent year.

In general, in most regions of Canada there are more females than males and this trend is particularly evident in areas with higher proportions of the population who are elderly. The preponderance of females in the older age groups is due to their higher life expectancy compared to males. In 2006, Saskatchewan had the highest proportion (17.1%) of the female population that was 65 years and over, while Alberta (11.9%), and the three territories (7.2% for Yukon, 4.9% for the Northwest Territories, and 2.6% for Nunavut) had the lowest proportions. The map shows by census subdivision the marital status of the population 15 years of age and over by gender.

This table contains 3114 series, with data for years 1996 - 1996 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (173 items: Canada; Health and Community Services St. John's Region; Newfoundland and Labrador (Peer group H);Health and Community Services Eastern Region; Newfoundland and Labrador (Peer group D);Newfoundland and Labrador ...), Age group (2 items: At birth; At age 65 ...), Sex (3 items: Both sexes; Males; Females ...), Characteristics (3 items: Disability-adjusted life expectancy; Low 95% confidence interval; disability-adjusted life expectancy; High 95% confidence interval; disability-adjusted life expectancy ...).

BackgroundBehaviours such as smoking, poor diet, physical inactivity, and unhealthy alcohol consumption are leading risk factors for death. We assessed the Canadian burden attributable to these behaviours by developing, validating, and applying a multivariable predictive model for risk of all-cause death.MethodsA predictive algorithm for 5 y risk of death—the Mortality Population Risk Tool (MPoRT)—was developed and validated using the 2001 to 2008 Canadian Community Health Surveys. There were approximately 1 million person-years of follow-up and 9,900 deaths in the development and validation datasets. After validation, MPoRT was used to predict future mortality and estimate the burden of smoking, alcohol, physical inactivity, and poor diet in the presence of sociodemographic and other risk factors using the 2010 national survey (approximately 90,000 respondents). Canadian period life tables were generated using predicted risk of death from MPoRT. The burden of behavioural risk factors attributable to life expectancy was estimated using hazard ratios from the MPoRT risk model.FindingsThe MPoRT 5 y mortality risk algorithms were discriminating (C-statistic: males 0.874 [95% CI: 0.867–0.881]; females 0.875 [0.868–0.882]) and well calibrated in all 58 predefined subgroups. Discrimination was maintained or improved in the validation cohorts. For the 2010 Canadian population, unhealthy behaviour attributable life expectancy lost was 6.0 years for both men and women (for men 95% CI: 5.8 to 6.3 for women 5.8 to 6.2). The Canadian life expectancy associated with health behaviour recommendations was 17.9 years (95% CI: 17.7 to 18.1) greater for people with the most favourable risk profile compared to those with the least favourable risk profile (88.2 years versus 70.3 years). Smoking, by itself, was associated with 32% to 39% of the difference in life expectancy across social groups (by education achieved or neighbourhood deprivation).ConclusionsMultivariable predictive algorithms such as MPoRT can be used to assess health burdens for sociodemographic groups or for small changes in population exposure to risks, thereby addressing some limitations of more commonly used measurement approaches. Unhealthy behaviours have a substantial collective burden on the life expectancy of the Canadian population.

In general, in most regions of Canada there are more females than males and this trend is particularly evident in areas with higher proportions of the population who are elderly. The preponderance of females in the older age groups is due to their higher life expectancy compared to males. In 2006, Saskatchewan had the highest proportion (17.1%) of the female population that was 65 years and over, while Alberta (11.9%), and the three territories (7.2% for Yukon, 4.9% for the Northwest Territories, and 2.6% for Nunavut) had the lowest proportions. The map shows the sex composition by age of the population by census subdivision.

Venlafaxine is an antidepressant and anti-anxiety drug that has been detected in municipal wastewater at low concentrations. To assess the potential of this compound to affect the survival, development and reproductive capacity of fish, we exposed Fathead minnow (Pimephales promelas) over a full lifecycle in a flow-through system to nominal venlafaxine concentrations. During the 167–168 day exposure, no significant changes were observed in survival, or the weights and lengths of Fathead minnows. At maturity, there were no significant differences relative to controls in condition factor, liver-somatic index, or secondary sex characteristics in the venlafaxine exposed male or female fish. Venlafaxine exposure at environmentally relevant concentrations caused no adverse effects in Fathead minnows. This study is the first to assess the potential for effects in fish exposed to the antidepressant venlafaxine over a full lifecycle. Supplemental Information The Chemicals Management Plan (CMP) is a Government of Canada initiative aimed at reducing the risks posed by chemicals to Canadians and their environment. A key element of the Chemicals Management Plan is the monitoring and surveillance of levels of harmful chemicals in Canadians and their environment. Monitoring and surveillance are essential to identify and track exposure to hazards in the environment and associated health implications. Monitoring and surveillance programs provide the basis for making sound and effective public health and environmental health policies and interventions, as well as measuring the efficacy of control measures. In support of the Chemicals Management Plan, monitoring and surveillance initiatives were established to support Health Canada and Environment and Climate Change Canada scientists, in collaboration with external partners and researchers, to advance our knowledge. This initiative has allowed the Government of Canada to increase its commitment to a number of existing monitoring initiatives, as well as to support new efforts. For more information on the Chemicals Management Plan, please visit https://www.canada.ca/en/health-canada/services/chemical-substances/chemicals-management-plan.html

Propranolol is a human pharmaceutical b-blocker that has been detected in municipal wastewater effluents in low concentrations. To assess the potential of this compound to affect fish, Fathead minnow (Pimephales promelas) were exposed for a life cycle in a flow-through system to nominal propranolol concentrations. During the 162-day to 165-day exposure, no significant changes in weights or lengths were seen in Fathead minnows, although the highest concentration of propranolol did cause a 15% decrease in survival of larval and juvenile stage fish compared with controls. At maturity, there were no significant changes in condition factor, liver-somatic index, or secondary sex characteristics in propranolol-exposed male or female fish. Female gonadosomatic index was significantly decreased in fish exposed to the highest concentrations of propranolol, probably because of increased egg-laying. Propranolol exposure caused no effects in Fathead minnows, except at the highest exposure concentration, where there were slight decreases in survival of juvenile minnows, and indications of increased reproduction. The present study is important because it is the first to assess the potential for effects in fish exposed to propranolol for a life cycle. Supplemental Information The Chemicals Management Plan (CMP) is a Government of Canada initiative aimed at reducing the risks posed by chemicals to Canadians and their environment. A key element of the Chemicals Management Plan is the monitoring and surveillance of levels of harmful chemicals in Canadians and their environment. Monitoring and surveillance are essential to identify and track exposure to hazards in the environment and associated health implications. Monitoring and surveillance programs provide the basis for making sound and effective public health and environmental health policies and interventions, as well as measuring the efficacy of control measures. In support of the Chemicals Management Plan, monitoring and surveillance initiatives were established to support Health Canada and Environment and Climate Change Canada scientists, in collaboration with external partners and researchers, to advance our knowledge. This initiative has allowed the Government of Canada to increase its commitment to a number of existing monitoring initiatives, as well as to support new efforts. For more information on the Chemicals Management Plan, please visit https://www.canada.ca/en/health-canada/services/chemical-substances/chemicals-management-plan.html